JNCE
Marshall Wace’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-39,339
| Closed | -$119K | – | 3519 |
|
|
2022
Q2 | $119K | Buy |
+39,339
| New | +$119K | ﹤0.01% | 2533 |
|
|
2021
Q4 | – | Sell |
-169,686
| Closed | -$1.26M | – | 3945 |
|
|
2021
Q3 | $1.26M | Sell |
169,686
-81,792
| -33% | -$608K | 0.01% | 1446 |
|
|
2021
Q2 | $1.71M | Buy |
251,478
+156,739
| +165% | +$1.07M | 0.01% | 1191 |
|
|
2021
Q1 | $973K | Buy |
+94,739
| New | +$973K | ﹤0.01% | 1409 |
|
|
2020
Q3 | – | Sell |
-84,369
| Closed | -$582K | – | 1981 |
|
|
2020
Q2 | $582K | Sell |
84,369
-171,770
| -67% | -$1.18M | ﹤0.01% | 1124 |
|
|
2020
Q1 | $1.22M | Sell |
256,139
-217,426
| -46% | -$1.03M | 0.01% | 748 |
|
|
2019
Q4 | $4.13M | Buy |
+473,565
| New | +$4.13M | 0.03% | 556 |
|
|
2019
Q1 | – | Sell |
-25,999
| Closed | -$88K | – | 2126 |
|
|
2018
Q4 | $88K | Buy |
+25,999
| New | +$88K | ﹤0.01% | 1383 |
|